Ignite Creation Date:
2024-05-06 @ 10:53 AM
Last Modification Date:
2024-10-26 @ 12:37 PM
Study NCT ID:
NCT03379428
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-12
First Post:
2017-12-12
Brief Title:
Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer
Sponsor:
US Oncology Research
Organization:
US Oncology Research